International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
Four adenosine receptors have been cloned and characterized from several mammalian species. The receptors are named adenosine A(1), A(2A), A(2B), and A(3). The A(2A) and A(2B) receptors preferably interact with members of the G(s) family of G proteins and the A(1) and A(3) receptors with G(i/o) proteins. However, other G protein interactions have also been described. Adenosine is the preferred endogenous agonist at all these receptors, but inosine can also activate the A(3) receptor. The levels of adenosine seen under basal conditions are sufficient to cause some activation of all the receptors, at least where they are abundantly expressed. Adenosine levels during, e.g., ischemia can activate all receptors even when expressed in low abundance. Accordingly, experiments with receptor antagonists and mice with targeted disruption of adenosine A(1), A(2A), and A(3) expression reveal roles for these receptors under physiological and particularly pathophysiological conditions. There are pharmacological tools that can be used to classify A(1), A(2A), and A(3) receptors but few drugs that interact selectively with A(2B) receptors. Testable models of the interaction of these drugs with their receptors have been generated by site-directed mutagenesis and homology-based modelling. Both agonists and antagonists are being developed as potential drugs.
Fredholm
B B
BB
Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden, The Netherlands. Bertil.Fredholm@fyfa.ki.se
IJzerman
A P
AP
Jacobson
K A
KA
Klotz
K N
KN
Linden
J
J
D000818:Animals; D006801:Humans; D010600:Pharmacology / Q000592:standards; D018047:Receptors, Purinergic P1 / Q000737:chemistry / Q000145:classification* / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D009626:Terminology as Topic
D018047:Receptors, Purinergic P1